Author:
Jadavji T,Prober C G,Cheung R
Abstract
Twenty clinical isolates of Haemophilus influenzae type b were used to determine the in vitro interactions of rifampin with ampicillin or chloramphenicol. Potential interactions of the drugs were evaluated by calculating the fractional inhibitory concentration index and fractional bactericidal concentration index for each strain after treatments with the drugs alone and in combination. There was no evidence of synergy or antagonisms between ampicillin and rifampin or between chloramphenicol and rifampin. With ampicillin-susceptible H. influenzae type b strains, an additive effect was observed with seven strains, and an indifferent effect was observed with three strains. Similarly, with chloramphenicol-susceptible H. influenzae type b strains, an additive effect was observed with eight strains, and an indifferent effect was observed with two strains.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference17 articles.
1. American Academy of Pediatrics. 1982. Report of the Committee on Infectious Diseases 9th ed. p. 105-107. American Academy of Pediatrics Evanston Ill.
2. Systemic Haemophilus influenzae disease;Dajani S. A.;J. Pediatr.,1979
3. An outbreak of Haemophilus influenzae type b meningitis in an enclosed hospital population;Glode M.;J. Pediatr.,1976
4. Haemophilus influenzae type b disease in a day care center. Eradication of carrier state by rifampin;Granoff D.;Pediatrics,1979
5. Analysis of in vitro antibacterial activities of the combination of trimethoprim and sulfamethoxazole on clinical isolates in Japan;Japan Cooperative Bacteriological Study Group for Co-Trimoxazole.;J. Infect. Dis.,1973
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献